Sponsor pipeline

Vera Therapeutics, Inc. clinical trial pipeline

4 active trials 1 recruiting 1 Phase 3 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2		3
Phase 3		1

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT04716231	Atacicept in Subjects With IgA Nephropathy	IgA Nephropathy	Active, Not Recruiting	2026-10-01
Phase 2
NCT06983028	Atacicept in Multiple Glomerular Diseases	pMN	Recruiting	2026-06-26
NCT06674577	A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept	IgA Nephropathy (IgAN)	Enrolling by Invitation	2026-06-22
NCT07020923	Monthly Dosing of Atacicept in IgAN	IgA Nephropathy (IgAN)	Active, Not Recruiting	2026-04-13

Get alerts when Vera Therapeutics, Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.